On Tuesday shares of Neogenomics Inc. (NASDAQ:NEO) closed at $4.73. Company’s sales growth for last 5 years was 24.20% and EPS growth for next 5 years is recorded as 20.00%. Neogenomics Inc. (NASDAQ:NEO) reported a net loss of $761,000 in the first quarter. In the first quarter of 2014, Neo Genomics had net income of $102,000.
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) in last trading activity fell -6.01% to close at $9.22. Company weekly performance is -15.02% while its quarterly performance stands at 3.25%. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) is -35.97% away from its 52 week high. On 27 April, ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced the initiation of a Phase 1b/2 study of Ad-RTS-hIL-12 + veledimex following standard chemotherapy for the treatment of patients with locally advanced or metastatic breast cancer.
On last trading day International Business Machines Corporation (NYSE:IBM) increased 1.87% to close at $173.92. Its volatility for the week is 2.14% while volatility for the month is 1.70%. IBM’s sales growth for past 5 years was -0.60% and its EPS growth for past 5 years was 9.30%. International Business Machines Corporation (NYSE:IBM) monthly performance is 8.43%.On 23 April, International Business Machines Corporation (NYSE:IBM) announced it is taking its QRadar-based security intelligence solution for cyber-threat analytics to the cloud in a SaaS model.
Noah Holdings Limited (NYSE:NOAH) has 49.22% insider ownership while its institutional ownership stands at 31.70%. In last trading activity company’s stock closed at $33.88. On 24 April, Noah Holdings Limited (NYSE:NOAH) announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2014 with the U.S. Securities and Exchange Commission.
On last trading day Amtech Systems Inc. (NASDAQ:ASYS) moved up 4.69% to close at $12.50. Its volatility for the week is 5.13% while volatility for the month is 5.07%. ASYS’s sales growth for past 5 years was 1.30% and its EPS growth for past 5 years was -49.40%. Amtech Systems Inc. (NASDAQ:ASYS) monthly performance is 14.57%.Benchmark Co. assumed coverage on shares of Amtech Systems Inc. (NASDAQ:ASYS) in a research note issued on Wednesday. The firm set a “buy” rating and a $16.00 price target on the stock. Benchmark Co.’s price target indicates a potential upside of 44.27% from the stock’s previous close.